RNA Selectively Modulates Activity of Virulent Amyloid PSMα3 and Host Defense LL-37 via Phase Separation and Aggregation Dynamics

This study reveals that RNA acts as a context-dependent regulator of the virulent amyloid peptide PSMα3 and the host-defense peptide LL-37 by modulating their phase separation and aggregation dynamics, thereby selectively preserving PSMα3's cytotoxicity while suppressing LL-37's toxicity to human cells without compromising its antibacterial function.

The Gist

The Big Picture: A Molecular Dance Floor

Imagine two dancers on a crowded floor.

1. PSMα3 is a "villain" dancer from a bacteria (Staphylococcus aureus). Its job is to be toxic, breaking down human cells and helping the bacteria build strong fortresses (biofilms).
2. LL-37 is a "hero" dancer from the human body. Its job is to fight bacteria and protect us.

Both dancers wear similar outfits (they are both made of alpha-helical structures), and they both love to hold hands with RNA (a molecule found in all living things, like a long, stringy piece of yarn).

The big question the scientists asked was: What happens when these dancers meet the yarn (RNA)? Does the yarn help them dance better, or does it trip them up?

The Discovery: RNA is a "Context-Dependent DJ"

The researchers found that RNA acts like a DJ who changes the music depending on who is dancing. It doesn't treat the villain and the hero the same way.

1. The Villain (PSMα3) and the Yarn: A Protective Shield

Normally, when the villain (PSMα3) is left alone, it gets tired and stops dancing. It clumps together into a big, solid, useless pile (aggregation) and loses its ability to hurt human cells.

• The Magic of RNA: When RNA is present, it acts like a stabilizing force.
  • At low concentrations: The RNA helps the villain form "liquid droplets" (like water beads). These droplets are dynamic and flexible. They keep the villain active and ready to attack for a longer time.
  • At high concentrations: The RNA forces the villain into a very specific, organized structure (fibrils) that remains toxic for a long time.
• The Result: RNA essentially keeps the villain alive and dangerous. It prevents the villain from getting "bored" and clumping up into a useless pile. This helps the bacteria survive and continue their attack on the host.

2. The Hero (LL-37) and the Yarn: A Safety Harness

The hero (LL-37) is naturally very good at killing bacteria. However, it can sometimes be too aggressive, accidentally hurting our own healthy cells (cytotoxicity) while fighting the bad guys.

• The Magic of RNA: When the hero meets RNA, the RNA acts like a safety harness.
  • It slows the hero down just enough so it stops hurting human cells.
  • Crucially, the hero still keeps its ability to kill bacteria.
• The Result: RNA helps the body fight the infection without causing as much collateral damage to its own tissues. It's a "smart" regulation that protects the host.

The "Morphing" Effect: Liquid vs. Solid

The paper explains that the shape these molecules take determines their power.

• Without RNA: The villain (PSMα3) eventually turns into a hard, solid rock (an inert aggregate). It can't move, so it can't attack.
• With RNA: The villain stays in a "liquid" or "semi-solid" state. Think of it like honey vs. a rock. Honey flows and can stick to things (attacking cells); a rock just sits there. RNA keeps the villain in the "honey" state, ensuring it remains toxic.

The "Bad Guy" Inhibitor (EGCG)

The scientists also tested a substance called EGCG (found in green tea), which is known to stop amyloid formation.

• What it did: EGCG acted like a glue gun. It forced both the villain and the hero to clump together into messy, shapeless blobs (amorphous aggregates).
• The Outcome: Because they were stuck in these messy blobs, neither could function. The villain couldn't attack, and the hero couldn't fight.
• The Lesson: This proves that the specific shape and flexibility of the molecules are what make them work. It's not just about them sticking together; it's about how they stick together.

Why This Matters

This research changes how we think about infections and immunity:

1. Bacteria are Smart: Bacteria might use the RNA floating around in our bodies (from our own dying cells) to keep their weapons (PSMα3) sharp and ready for a long fight.
2. Our Body is Smart: Our immune system might use RNA to dial down its own weapons (LL-37) so we don't hurt ourselves while fighting the infection.
3. New Treatments: Instead of just trying to "kill" the bacteria or "stop" the protein from clumping, doctors might be able to design drugs that change the shape of these molecules. If we can force the villain into a "rock" state (like EGCG did) or force the hero into a "liquid" state, we could control the infection much better.

Summary Analogy

Imagine a fire (the infection).

• PSMα3 is the fire spreading.
• LL-37 is the fire department trying to put it out.
• RNA is the wind.
  • For the fire (PSMα3), the wind (RNA) keeps the flames dancing and spreading, preventing them from dying out.
  • For the fire department (LL-37), the wind (RNA) helps them aim better, stopping them from accidentally burning down the neighborhood while they fight the fire.

The paper shows that the environment (RNA) dictates whether these molecular tools are sharp weapons or dull rocks.

Technical Summary

1. Problem Statement

Bacterial amyloids, such as Phenol-soluble modulins (PSMs) from Staphylococcus aureus, are critical virulence factors that form ordered fibrils (specifically cross-α amyloids) to mediate cytotoxicity, immune modulation, and biofilm stability. Conversely, the human host-defense peptide LL-37 shares structural similarities with PSMα3 (cationic, amphipathic α-helices) but forms non-amyloid assemblies.

While it is known that nucleic acids can regulate protein phase behavior, the specific mechanisms by which RNA modulates the assembly landscapes, material properties, and biological activities of these structurally distinct but functionally related peptides remain unexplored. The study seeks to determine if RNA acts as a universal regulator or a context-dependent modulator that differentially influences the virulence of bacterial peptides versus the host defense mechanisms of human peptides.

2. Methodology

The researchers employed a multidisciplinary approach combining biophysical, structural, and cellular assays:

• Peptide-RNA Interaction Assays:
  • Electrophoretic Mobility Shift Assay (EMSA): Used to determine binding affinity between PSMα3 and single-stranded (Poly A) vs. double-stranded (Poly AU) RNA.
  • Turbidity Assays: Measured light scattering to assess concentration-dependent aggregation and phase separation.
• Structural and Morphological Characterization:
  • Fluorescence Microscopy & FRAP: Visualized liquid-liquid phase separation (LLPS) and condensate dynamics using FITC-labeled peptides and Propidium Iodide (PI)-labeled RNA. Fluorescence Recovery After Photobleaching (FRAP) quantified molecular mobility within condensates.
  • Transmission Electron Microscopy (TEM): Analyzed fibril morphology (twisted sheets, nanotubes, amorphous aggregates) at various RNA concentrations and incubation times.
  • TIRF Microscopy: Used AmyTracker630 to detect amyloid-like species formation kinetics.
  • Solid-State Circular Dichroism (ssCD): Assessed secondary structure stabilization (α-helical content) in the presence of RNA.
  • NMR Spectroscopy: Investigated residue-specific interactions between PSMα3 and the amyloid inhibitor EGCG.
• Biological Activity Assays:
  • Cytotoxicity: Measured Lactate Dehydrogenase (LDH) release in HeLa cells to quantify membrane damage.
  • Antimicrobial Activity: Used PrestoBlue assays to measure E. coli viability.
  • Live-Cell Imaging: Confocal and super-resolution microscopy tracked peptide localization, nuclear entry (nucleolus), and membrane disruption in real-time.
• Comparative Modulators: The study compared RNA effects with Epigallocatechin gallate (EGCG), a known amyloid inhibitor, to distinguish between regulatory modulation and irreversible inhibition.

3. Key Contributions and Results

A. RNA Binding and Phase Behavior of PSMα3

• Binding Affinity: PSMα3 binds double-stranded Poly (AU) RNA with higher affinity ($K_d \approx 61.8 \mu M$) than single-stranded Poly (A) RNA ($K_d \approx 94.5 \mu M$), exhibiting cooperative binding.
• Concentration-Dependent Phase Transitions:
  • Low RNA Concentration (50 ng/µL): Induces Liquid-Liquid Phase Separation (LLPS). PSMα3 and RNA form dynamic, liquid-like droplets that colocalize. These droplets show rapid fluorescence recovery (FRAP half-time ~3.1s) but age over time (2 hours) into solid-like aggregates.
  • High RNA Concentration (400 ng/µL): Promotes immediate, rapid aggregation into solid, amorphous or fibrillar structures without a liquid intermediate.
• Structural Stabilization: RNA enhances the $\alpha$-helical signature of PSMα3, stabilizing the cross-α amyloid architecture.

B. Differential Modulation of Biological Activity

• PSMα3 (Bacterial Virulence Factor):
  • Without RNA: PSMα3 loses cytotoxicity and antimicrobial activity over time (24h) as it matures into inert, dense fibrils.
  • With RNA: RNA preserves and sustains PSMα3 toxicity. By reshaping the assembly landscape (promoting dynamic intermediates or specific fibrillar polymorphs), RNA prevents the "deactivation" of the peptide. High RNA concentrations maintain cytotoxicity even after 24 hours.
  • Cellular Localization: PSMα3 enters HeLa cells and accumulates in the nucleolus, colocalizing with nucleic acids, suggesting a mechanism for intracellular toxicity or sequestration.
• LL-37 (Human Host Defense):
  • Effect of RNA: In contrast to PSMα3, RNA reduces the cytotoxicity of LL-37 against human cells in a concentration-dependent manner.
  • Antimicrobial Preservation: Crucially, RNA does not compromise LL-37's antibacterial activity against E. coli.
  • Mechanism: RNA drives LL-37 into amorphous, solid-like aggregates (especially under thermal stress), effectively sequestering the toxic species from human membranes while retaining antimicrobial function.

C. The Role of EGCG (Inhibitor vs. Regulator)

• EGCG binds PSMα3 and redirects assembly into non-functional amorphous aggregates, completely abolishing both cytotoxicity and antimicrobial activity.
• Unlike RNA, which acts as a regulatory modulator (tuning the assembly state to maintain function), EGCG acts as an irreversible inhibitor that creates structural dead ends. This highlights that biological activity depends on specific supramolecular architecture and reversibility, not merely the presence of aggregation.

4. Significance and Implications

• RNA as an Environmental Switch: The study establishes RNA as a critical environmental regulator that tunes the virulence of bacterial amyloids and the safety of host peptides. In infection sites (biofilms, abscesses), high concentrations of extracellular RNA may act as a reservoir for PSMα3, maintaining its toxicity over time.
• Divergent Evolutionary Outcomes:
  • For S. aureus, RNA-mediated stabilization of PSMα3 intermediates enhances virulence and immune evasion.
  • For the host, RNA-mediated sequestration of LL-37 into amorphous aggregates serves a protective function, minimizing collateral tissue damage (cytotoxicity) while preserving pathogen clearance.
• Therapeutic Insights: The findings challenge the view that aggregation is inherently toxic or that inhibition is always beneficial. Instead, they suggest that therapeutic strategies for amyloid-related diseases or infections should focus on modulating assembly pathways (e.g., preventing the formation of specific toxic intermediates) rather than simply blocking aggregation.
• Broader Context: The work draws parallels between bacterial virulence factors and human RNA-binding proteins (like FUS or TDP-43), suggesting that phase transitions and RNA-mediated assembly dynamics are a universal mechanism for regulating peptide function across the host-pathogen interface.

In summary, the paper reveals a sophisticated "molecular tug-of-war" where RNA differentially controls the fate of bacterial and host peptides: sustaining the virulence of the pathogen while dampening the collateral damage of the host defense, all through the precise tuning of phase separation and aggregation dynamics.